Prothena reported $0 in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Agios Pharmaceuticals AGIO:US $ 0.41M 0.59M
Akebia Therapeutics AKBA:US $ 97.23M 0.31M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
ALKERMES ALKS:US $ 296.44M 0.63M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 37579M 4797M
Biogen BIIB:US $ 7271.1M 1.9M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Exelixis EXEL:US $ 0M 0M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
Macrogenics MGNX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Prothena PRTA:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 33.78M 0.47M